EUVIMEDEUVIMED entdecken
Crossref

Doxorubicin carrier based on an HCOF platform for potent cancer therapy

Tingyan Jiang, Meng Liu, Jiarui Qiao, Wenjing Wei, Xianhao Wei iD, Luwen Zhang, Yan Wang, Junhe Ou, Maolin Pang iD

Dalton Transactions · 2025

DOI: 10.1039/d5dt00486a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2025. Verfasst von Tingyan Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541001, P. R. China. mlpang@gxnu.edu.cn. Hauptthemen laut MEDLINE: Doxorubicin, Drug Carriers, Metal-Organic Frameworks, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Specific Research Project of Guangxi for Research Bases and Talents, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is widely used in cancer treatment, and an effective drug carrier is usually needed to overcome its serious side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDrug CarriersMetal-Organic FrameworksAntineoplastic AgentsAntibiotics, AntineoplasticHumansAnimalsMiceCell Line, TumorDrug LiberationNeoplasmsCell ProliferationDrug Screening Assays, Antitumor

Substanzen

DoxorubicinDrug CarriersMetal-Organic FrameworksAntineoplastic AgentsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541001, P. R. China. mlpang@gxnu.edu.cn.

ORCID-Profile: Xianhao Wei, Maolin Pang

Förderung

  • Specific Research Project of Guangxi for Research Bases and Talents
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, T., Liu, M., Qiao, J., Wei, W., Wei, X., Zhang, L., Wang, Y., Ou, J., & Pang, M. (2025). Doxorubicin carrier based on an HCOF platform for potent cancer therapy. Dalton Transactions. https://doi.org/10.1039/d5dt00486a

Vancouver

Jiang T, Liu M, Qiao J, Wei W, Wei X, Zhang L, et al. Doxorubicin carrier based on an HCOF platform for potent cancer therapy. Dalton Transactions. 2025. doi:10.1039/d5dt00486a

BibTeX
@article{Jiang2025,
  author = {Jiang, Tingyan and Liu, Meng and Qiao, Jiarui and Wei, Wenjing and Wei, Xianhao and Zhang, Luwen and Wang, Yan and Ou, Junhe and Pang, Maolin},
  title = {Doxorubicin carrier based on an HCOF platform for potent cancer therapy},
  journal = {Dalton Transactions},
  year = {2025},
  doi = {10.1039/d5dt00486a}
}
Kostenlos starten →